ACET vs BXP · $75.7M cap vs rev $3.48B
Adicet Bio Inc (ACET) versus Boston Properties Inc (BXP) — a side-by-side from cached financials, not a winner call.
Adicet Bio Inc (ACET) is a biotechnology company listed on NASDAQ.
Boston Properties Inc (BXP) is a reit - office company listed on US.
ACET does not have a complete income-statement cache yet.
Latest reported BXP revenue for 2025-12-31 was $3.48B. Net income was $276.8M. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BXP currently screens at market cap $12.12B.
ACET currently screens at market cap $75.7M. BXP currently screens at market cap $12.12B.
Not investment advice. Open the ACET and BXP stock pages for the full models.
Not investment advice.